Showing of 0 - 10 from 60 results
Ranbaxy laboratories - Total results - 60
Aug 11, 2015
Sun Pharma Q1 net profit down by 60% over integration woesTotal income of the company increased however to Rs 6,767.58 crore during the first quarter of 2015-16 as against Rs 6,341.21 crore for the year ago period.
May 29, 2015
Sun Pharma reports Q4 net profit at Rs 888 cr, Ranbaxy deal shrinks earningsNet sales of the company stood at Rs 27,286.50 crore for the year ended March 31. The same stood at Rs 16,004.39 crore in the last year.
Apr 22, 2015
Daiichi Sankyo's misery ends, block deal to give company coup de grâceEven after allowing for control premium, the price that Daiichi Sankyo paid for Ranbaxy Laboratories was clearly excessive, and those in the know said sagely that winner’s curse would have its say sooner than later.
Oct 28, 2014
Ranbaxy posts profit of Rs 478 crore in Q2, shares up 7%Generic drugmaker Ranbaxy Laboratories Ltd, which is in the process of being acquired by larger rival Sun Pharmaceutical Industries Ltd, reported a profit in its second quarter
Mar 09, 2014
Ranbaxy gets prescription wrong on Lipitor, recalls 64,000 bottles in USRanbaxy recalled tablets of atorvastatin calcium, the generic version of Pfizer Inc's cholesterol fighter Lipitor, after a pharmacist found a 20-milligram tablet in a sealed bottle marked for 10-milligram tablets, the U.S. Food and Drug Administration (FDA) said on its website.
Jan 24, 2014
FDA ban: Ranbaxy to take 'appropriate action' for lapses at ToansaRanbaxy Laboaratories today said it will take 'appropriate management action' for the lapses at the manufacturing facility after the conclusion of an internal investigation.<br /><br />
Jan 13, 2014
USFDA raises concerns over production practices Ranbaxy's Toansa plantThe US Food and Drug Administration's observations regarding the manufacturing practices in the company's plant in Punjab comes after the recent inspection of the facility by the health regulator.<br /><br />
Jan 09, 2014
Ranbaxy signs licensing pact with EPIRUS SwitzerlandUnder the terms of the agreement, EPIRUS will develop and supply the product; and upon regulatory approval, Ranbaxy will market the same in India and other emerging markets.
Oct 21, 2013
Ranbaxy gets nod to sell malaria drug 'SynriamTM' in IndiaDrug major Ranbaxy Laboratories today said it has received Indian drug regulator's approval to market SynriamTM for treating malaria caused by Plasmodium vivax parasite.
Oct 02, 2013
Ranbaxy says it has no plans to reduce workforcePharmaceuticals major Ranbaxy Laboratories today said it has no plans to reduce its workforce and is focusing on improving performance and productivity.